These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31900731)

  • 1. Guar Gum Micro-particles for Targeted Co-delivery of Doxorubicin and Metformin HCL for Improved Specificity and Efficacy Against Colon Cancer: In Vitro and In Vivo Studies.
    Kang RK; Mishr N; Rai VK
    AAPS PharmSciTech; 2020 Jan; 21(2):48. PubMed ID: 31900731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the development of colon-targeted delivery systems for celecoxib in the prevention of colorectal cancer.
    Krishnaiah YS; Satyanarayana V; Kumar BD; Karthikeyan RS
    J Drug Target; 2002 May; 10(3):247-54. PubMed ID: 12075826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro drug release studies on guar gum-based colon targeted oral drug delivery systems of 5-fluorouracil.
    Krishnaiah YS; Satyanarayana V; Dinesh Kumar B; Karthikeyan RS
    Eur J Pharm Sci; 2002 Aug; 16(3):185-92. PubMed ID: 12128173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential of guar gum microspheres for target specific drug release to colon.
    Chourasia MK; Jain SK
    J Drug Target; 2004; 12(7):435-42. PubMed ID: 15621668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guar gum/ethylcellulose coated pellets for colon-specific drug delivery.
    Ji CM; Xu HN; Sun NY; Lu YP; Wu W
    Yao Xue Xue Bao; 2007 Jun; 42(6):656-62. PubMed ID: 17702405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid conjugated guar gum nanoparticles for targeting methotrexate to colon cancer.
    Sharma M; Malik R; Verma A; Dwivedi P; Banoth GS; Pandey N; Sarkar J; Mishra PR; Dwivedi AK
    J Biomed Nanotechnol; 2013 Jan; 9(1):96-106. PubMed ID: 23627072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the development of oral colon targeted drug delivery systems for metronidazole in the treatment of amoebiasis.
    Krishnaiah YS; Bhaskar Reddy PR; Satyanarayana V; Karthikeyan RS
    Int J Pharm; 2002 Apr; 236(1-2):43-55. PubMed ID: 11891069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of guar gum compression-coated 5-aminosalicylic acid tablets for colon-specific drug delivery.
    Krishnaiah YS; Satyanarayana S; Prasad YV
    Drug Dev Ind Pharm; 1999 May; 25(5):651-7. PubMed ID: 10219535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-fluorouracil loaded guar gum microspheres for colon delivery: preparation, characterization and in vitro release.
    Kaushik D; Sardana S; Mishra DN
    Yao Xue Xue Bao; 2009 Nov; 44(11):1278-84. PubMed ID: 21351727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tabletted guar gum microspheres of piroxicam for targeted adjuvant therapy for colonic adenocarcinomas.
    Vats A; Pathak K
    Ther Deliv; 2012 Nov; 3(11):1281-95. PubMed ID: 23259249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guar gum as a carrier for colon specific delivery; influence of metronidazole and tinidazole on in vitro release of albendazole from guar gum matrix tablets.
    Krishnaiah YS; Seetha Devi A; Nageswara Rao L; Bhaskar Reddy PR; Karthikeyan RS; Satyanarayana V
    J Pharm Pharm Sci; 2001; 4(3):235-43. PubMed ID: 11737989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of colon targeted drug delivery systems for mebendazole.
    Krishnaiah YS; Veer Raju P; Dinesh Kumar B; Bhaskar P; Satyanarayana V
    J Control Release; 2001 Nov; 77(1-2):87-95. PubMed ID: 11689262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesoporous silica nanoparticle based enzyme responsive system for colon specific drug delivery through guar gum capping.
    Kumar B; Kulanthaivel S; Mondal A; Mishra S; Banerjee B; Bhaumik A; Banerjee I; Giri S
    Colloids Surf B Biointerfaces; 2017 Feb; 150():352-361. PubMed ID: 27847225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporation of beads into oral films for buccal and oral delivery of bioactive molecules.
    Castro PM; Sousa F; Magalhães R; Ruiz-Henestrosa VMP; Pilosof AMR; Madureira AR; Sarmento B; Pintado ME
    Carbohydr Polym; 2018 Aug; 194():411-421. PubMed ID: 29801856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH-enzyme di-dependent chronotherapeutic drug delivery system of theophylline for nocturnal asthma.
    Soni ML; Namdeo KP; Jain SK; Gupta M; Dangi JS; Kumar M; Dangi YS
    Chem Pharm Bull (Tokyo); 2011; 59(2):191-5. PubMed ID: 21297298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation and comparison of colon specificity of novel polymer khaya gum with guar gum.
    Prabhu P; Ahamed N; Matapady HN; Ahmed MG; Narayanacharyulu R; Satyanarayana D; Subrahmanayam E
    Pak J Pharm Sci; 2010 Jul; 23(3):259-65. PubMed ID: 20566437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro and In-vivo Pharmacokinetic Evaluation of Guar Gum-Eudragit® S100 Based Colon-targeted Spheroids of Sulfasalazine Co-administered with Probiotics.
    Sharma A; Kumar B; Singh SK; Gulati M; Vaidya Y; ; Rathee H; Ghai D; Malik AH; Yadav AK; Maharshi P; Bawa P; Rajesh SY; Sharma P; Pandey NK; Mohanta S
    Curr Drug Deliv; 2018; 15(3):367-387. PubMed ID: 29219056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in guar gum based drug delivery systems and their administrative routes.
    Verma D; Sharma SK
    Int J Biol Macromol; 2021 Jun; 181():653-671. PubMed ID: 33766594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development, characterization and In-vitro evaluation of guar gum based new polymeric matrices for controlled delivery using metformin HCl as model drug.
    Ashames A; Ullah K; Al-Tabakha M; Khan SA; Hassan N; Mannan A; Ikram M; Buabeid M; Murtaza G
    PLoS One; 2022; 17(7):e0271623. PubMed ID: 35901085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo evaluation of guar gum-based matrix tablets of rofecoxib for colonic drug delivery.
    Al-Saidan SM; Krishnaiah YS; Satyanarayana V; Rao GS
    Curr Drug Deliv; 2005 Apr; 2(2):155-63. PubMed ID: 16305416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.